Concepedia

Author

Antony Sabin

GlaxoSmithKline (United Kingdom)

Also Known As

ANTONY J. SABIN, Antony Sabin

10

Publications

393

Citations

6

H-Index

19

Concepts

All Affiliations

GlaxoSmithKline (United Kingdom)
AS

About

Antony Sabin is an author at GlaxoSmithKline (United Kingdom) specializing in medicine, pharmacotherapy, and pharmacology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

291

2

Pharmacology

3

3

264

3

Management

1

1

27

4

Bayesian Decision Theory

1

1

27

5

Bayesian Inference

1

1

27

Antony Sabin

×

6

Publications

390

Citations

6

H-Index

YearCitations

A PHASE II DOSE-RANGING STUDY OF SITAMAQUINE FOR THE TREATMENT OF VISCERAL LEISHMANIASIS IN INDIA

T. K. Jha, Shyam Sundar, Chandreshwar Prasad Thakur,

American Journal of Tropical Medicine and Hygiene

2005

137

A PHASE II DOSE-INCREASING STUDY OF SITAMAQUINE FOR THE TREATMENT OF VISCERAL LEISHMANIASIS IN KENYA

MONIQUE K. WASUNNA, JUMA R. RASHID, JANE MBUI,

American Journal of Tropical Medicine and Hygiene

2005

86

TRAIL receptor agonist conatumumab with modified FOLFOX6 plus bevacizumab for first‐line treatment of metastatic colorectal cancer

Charles S. Fuchs, Marwan Fakih, Lee S. Schwartzberg,

Cancer

2013

65

Effects of encapsulation on absorption of sumatriptan tablets: data from healthy volunteers and patients during a migraine

Eliane Fuseau, Olivier Pétricoul, Antony Sabin,

Clinical Therapeutics

2001

41

Correlation Between Early Endpoints and Overall Survival in Non-Small-Cell Lung Cancer: A Trial-Level Meta-Analysis

Khader Shameer, Youyi Zhang, Dan Jackson,

Frontiers in Oncology

2021

34

An evaluation of Bayesian designs for dose-escalation studies in healthy volunteers

John Whitehead, Yinghui Zhou, Adrian Mander,

Statistics in Medicine

2005

27

Page 1